Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Jyrki, Lötjönen"'
Autor:
Mikko Koivumäki, Laura Ekblad, Juan Lantero-Rodriguez, Nicholas J. Ashton, Thomas K. Karikari, Semi Helin, Riitta Parkkola, Jyrki Lötjönen, Henrik Zetterberg, Kaj Blennow, Juha O. Rinne, Anniina Snellman
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-15 (2024)
Abstract Background Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β (Aβ) plaques, neurofibrillary tau tangles, and neurodegeneration in the brain parenchyma. Here, we aimed to (i) assess differences in blood and imaging
Externí odkaz:
https://doaj.org/article/ec950c17ae934bbbad1dedba707143df
Autor:
Aniek M. van Gils, Hanneke F. M. Rhodius-Meester, Dédé Handgraaf, Heleen M. A. Hendriksen, Astrid van Strien, Niki Schoonenboom, Annemieke Schipper, Mariska Kleijer, Annemiek Griffioen, Majon Muller, Antti Tolonen, Jyrki Lötjönen, Wiesje M. van der Flier, Leonie N. C. Visser
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-14 (2024)
Abstract Background Both memory clinic professionals and patients see value in digital tools, yet these hardly find their way to clinical practice. We explored the usability of a digital tool to support the diagnostic work-up in daily memory clinic p
Externí odkaz:
https://doaj.org/article/f0bec7b8e71a414fbd5ad2e4051e493a
Autor:
Anne Arola, Hanna M. Laakso, Heidi Heinonen, Johanna Pitkänen, Matti Ahlström, Juha Lempiäinen, Teemu Paajanen, Jussi Virkkala, Juha Koikkalainen, Jyrki Lötjönen, Antti Korvenoja, Susanna Melkas, Hanna Jokinen
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 6, Iss , Pp 100332- (2024)
Introduction: Subjective cognitive complaints are common in patients with cerebral small vessel disease (SVD), yet their correspondence to informant evaluations, objective cognitive functions and severity of brain changes are poorly understood. We st
Externí odkaz:
https://doaj.org/article/28d376b01fe2404c9257f2f17d3be4f4
Autor:
Hanna Jokinen, Hanna M. Laakso, Matti Ahlström, Anne Arola, Juha Lempiäinen, Johanna Pitkänen, Teemu Paajanen, Sietske A.M. Sikkes, Juha Koikkalainen, Jyrki Lötjönen, Antti Korvenoja, Timo Erkinjuntti, Susanna Melkas
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 6, Iss , Pp 100061- (2024)
Externí odkaz:
https://doaj.org/article/6297a6c3d57e4c0da880b2db78dd928a
Autor:
Marge Kartau, Susanna Melkas, Joonas Kartau, Anne Arola, Hanna Laakso, Johanna Pitkänen, Matti Ahlström, Juha Lempiäinen, Juha Koikkalainen, Jyrki Lötjönen, Antti Korvenoja, Sanna-Kaisa Herukka, Timo Erkinjuntti, Hanna Jokinen
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 6, Iss , Pp 100070- (2024)
Externí odkaz:
https://doaj.org/article/60145132c5204f12b661658d72130c23
Autor:
Anne Arola, Tuuli Levänen, Hanna M. Laakso, Johanna Pitkänen, Juha Lempiäinen, Matti Ahlström, Juha Koikkalainen, Jyrki Lötjönen, Antti Korvenoja, Timo Erkinjuntti, Susanna Melkas, Hanna Jokinen
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 6, Iss , Pp 100089- (2024)
Externí odkaz:
https://doaj.org/article/de66f530acb6474a9d63bffa359d4ab2
Autor:
Hanneke F M Rhodius-Meester, Ingrid S van Maurik, Lyduine E Collij, Aniek M van Gils, Juha Koikkalainen, Antti Tolonen, Yolande A L Pijnenburg, Johannes Berkhof, Frederik Barkhof, Elsmarieke van de Giessen, Jyrki Lötjönen, Wiesje M van der Flier
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303111 (2024)
BackgroundThe use of amyloid-PET in dementia workup is upcoming. At the same time, amyloid-PET is costly and limitedly available. While the appropriate use criteria (AUC) aim for optimal use of amyloid-PET, their limited sensitivity hinders the trans
Externí odkaz:
https://doaj.org/article/3ee1ec89908740e789f246a71d9f7bfa
Autor:
Ashley Tate, Marc Suárez-Calvet, Mats Ekelund, Sven Eriksson, Maria Eriksdotter, Wiesje M. Van Der Flier, Jean Georges, Miia Kivipelto, Milica G. Kramberger, Peter Lindgren, Juan Domingo Gispert López, Jyrki Lötjönen, Sofie Persson, Sandra Pla, Alina Solomon, Lennart Thurfjell, Anders Wimo, Bengt Winblad, Linus Jönsson, on behalf of the PROMINENT consortium
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually. Recent advances in diag
Externí odkaz:
https://doaj.org/article/8d18cf280d3344c9a30621b4dcd27bc6
Autor:
Anne Arola, Hanna M. Laakso, Heidi Heinonen, Johanna Pitkänen, Matti Ahlström, Juha Lempiäinen, Teemu Paajanen, Jussi Virkkala, Juha Koikkalainen, Jyrki Lötjönen, Antti Korvenoja, Susanna Melkas, Hanna Jokinen
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 5, Iss , Pp 100182- (2023)
Objective: Subjective cognitive complaints are common in patients with cerebral small vessel disease (cSVD), yet their relationship with informant evaluations, objective cognitive functions and severity of brain changes are poorly understood. We stud
Externí odkaz:
https://doaj.org/article/f270709120a2423b9ad852268bb02662
Autor:
Marge Kartau, Susanna Melkas, Joonas Kartau, Anne Arola, Hanna Laakso, Johanna Pitkänen, Juha Lempiäinen, Juha Koikkalainen, Jyrki Lötjönen, Antti Korvenoja, Matti Ahlström, Sanna-Kaisa Herukka, Timo Erkinjuntti, Hanna Jokinen
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2023)
BackgroundThe usefulness of neurofilament light (NfL) as a biomarker for small vessel disease has not been established. We examined the relationship between NfL, neuroimaging changes, and clinical findings in subjects with varying degrees of white ma
Externí odkaz:
https://doaj.org/article/f34f58a330184fe0a784af8f6d73d6e3